Breaking News Instant updates and real-time market news.

RGLS

Regulus

$0.36

0.02 (5.88%)

, SNY

Sanofi

$41.84

-0.65 (-1.53%)

07:39
07/10/18
07/10
07:39
07/10/18
07:39

Regulus downgraded to Neutral at Wedbush

As previously reported, Wedbush analyst Liana Moussato downgraded Regulus (RGLS) to Neutral from Outperform after he extended developmental timelines due to partnership restructuring with Sanofi (SNY) pausing clinical enrollment for RG-012 and unexpected mouse toxicity observations delaying clinical progress for RGLS4326. The analyst also lowered his price target on Regulus shares to $1 from $3.

RGLS

Regulus

$0.36

0.02 (5.88%)

SNY

Sanofi

$41.84

-0.65 (-1.53%)

  • 12

    Jul

  • 20

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

RGLS Regulus
$0.36

0.02 (5.88%)

01/05/18
01/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Becton Dickinson (BDX) initiated with an Overweight at KeyBanc. 2. Syndax (SNDX) initiated with a Buy at B. Riley FBR. 3. Sutherland Asset Management (SLD) initiated with an Outperform at JMP Securities. 4. Nike (NKE) was assumed with a Buy at Buckingham while Under Armour (UA, UAA) was assumed with a Neutral. 5. Regulus (RGLS) initiated with an Outperform at Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/18
RILY
03/27/18
INITIATION
Target $1
RILY
Neutral
Regulus initiated with a Neutral at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Regulus Therapeutics with a Neutral rating and $1 price target. The analyst believes the company is facing uncertainty in orphan kidney disease.
07/06/18
WELS
07/06/18
NO CHANGE
Target $0.5
WELS
Market Perform
Regulus price target lowered to 50c from $1.50 at Wells Fargo
Wells Fargo analyst Jim Birchenough lowered his price target for Regulus Therapeutics to the company's approximate cash level of 50c following the interruption of the Phase 1 study of anti-miR therapeutic RGLS4326 in autosomal dominant polycystic kidney disease due to unexpected preclinical toxicity and need for additional preclinical work. With "limited cash runway and continued unpredictable effects of its anti-miR therapeutic candidates," the analyst sees continued overhang and need to monetize earlier pipeline assets to support a recovery in shares of Regulus. He keeps a Market Perform rating on the name.
07/10/18
WEDB
07/10/18
DOWNGRADE
WEDB
Neutral
Regulus downgraded to Neutral from Outperform at Wedbush
SNY Sanofi
$41.84

-0.65 (-1.53%)

05/23/18
LEHM
05/23/18
NO CHANGE
Target $290
LEHM
Underweight
Regeneron product concentration remains big risk, says Barclays
Barclays analyst Geoff Meacham says his analysis suggests Eylea concentration remains a big risk for Regeneron Pharmaceuticals (REGN). A scenario analysis shows the company's adjusted earnings is sensitive to even modest changes to U.S. Eylea sales versus any product under the Sanofi (SNY) joint venture, namely Dupixent, Praluent, and Kevzara, Meacham tells investors in a research note. The analyst reiterates an Underweight rating on Regeneron with a $290 price target.
06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/28/18
WELS
06/28/18
NO CHANGE
WELS
Wells says Amazon deal, Walgreens results have negative read for drug pricing
After Amazon (AMZN) agreed to acquire online pharmacy PillPack, reportedly for $1B, Wells Fargo analyst David Maris noted that he has long stated that Amazon would enter the pharmacy business and warned about the risk to drug pricing in such a scenario. Maris also noted that Walgreens (WBA) reported its U.S. retail pharmacy comparable store sales fell 1.2% in Q3, adding that retailers tend to push drugmakers on price when they feel pressure and the read-through from its report may be negative for drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/02/18
PIPR
07/02/18
NO CHANGE
Target $450
PIPR
Overweight
Regeneron has 'substantial' opportunity for Q2 upside, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond says that with Dupixent script trends indicated up almost 30% quarter-over-quarter, Regeneron's (REGN) opportunity for Q2 upside is "substantial." Further, Regeneron and Sanofi (SNY) over the weekend raised the list price by 3% for the drug's first ever price increase, Raymond tells investors in a research note. He thinks Dupixent remains well positioned to outperform expectations "this quarter and beyond." The analyst maintains an Overweight rating on Regeneron with a $450 price target.

TODAY'S FREE FLY STORIES

02:40
07/20/18
07/20
02:40
07/20/18
02:40
General news
FX Update: The Dollar has been trading with a softer bias »

FX Update: The Dollar has…

02:35
07/20/18
07/20
02:35
07/20/18
02:35
General news
China bourses in late rally after yuan devaluation »

China bourses in late…

01:50
07/20/18
07/20
01:50
07/20/18
01:50
General news
The PBoC devalued the Yuan »

The PBoC devalued the…

01:45
07/20/18
07/20
01:45
07/20/18
01:45
General news
Asian Market Outlook: »

Asian Market Outlook:…

23:55
07/19/18
07/19
23:55
07/19/18
23:55
General news
Japan's core CPI improved to a 0.8% pace in June »

Japan's core CPI…

YUMC

Yum China

$36.00

-0.8 (-2.17%)

20:46
07/19/18
07/19
20:46
07/19/18
20:46
Downgrade
Yum China rating change at BofA/Merrill »

Yum China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 10

    Sep

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

20:45
07/19/18
07/19
20:45
07/19/18
20:45
Downgrade
Mersana Therapeutics rating change at Leerink »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$13.73

-0.02 (-0.15%)

, HON

Honeywell

$147.57

-1.58 (-1.06%)

20:25
07/19/18
07/19
20:25
07/19/18
20:25
Earnings
Notable companies reporting before tomorrow's openGentex »

Notable companies…

GE

General Electric

$13.73

-0.02 (-0.15%)

HON

Honeywell

$147.57

-1.58 (-1.06%)

SLB

Schlumberger

$66.91

-0.16 (-0.24%)

BHGE

Baker Hughes

$31.75

-0.79 (-2.43%)

STT

State Street

$92.84

-2.505 (-2.63%)

VFC

VF Corp.

$89.21

1 (1.13%)

STI

SunTrust

$69.00

-0.85 (-1.22%)

SWK

Stanley Black & Decker

$139.60

1.33 (0.96%)

RF

Regions Financial

$17.62

-0.43 (-2.38%)

CFG

Citizens Financial

$40.66

-0.365 (-0.89%)

KSU

Kansas City Southern

$108.48

1.93 (1.81%)

GNTX

Gentex

$23.41

-0.41 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

  • 08

    Aug

  • 19

    Oct

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

20:11
07/19/18
07/19
20:11
07/19/18
20:11
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Aug

  • 27

    Aug

CDNS

Cadence Design

$45.24

-0.29 (-0.64%)

20:04
07/19/18
07/19
20:04
07/19/18
20:04
Hot Stocks
Cadence Design announces Sigrity 2018 release »

Cadence Design announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

AVA

Avista

$50.40

0.06 (0.12%)

19:33
07/19/18
07/19
19:33
07/19/18
19:33
Hot Stocks
Idaho Public Utilities Commission postpones Avista and Hydro One merger hearing »

Hydro One Limited and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

CRK

Comstock Resources

$11.35

-0.2 (-1.73%)

19:28
07/19/18
07/19
19:28
07/19/18
19:28
Hot Stocks
Comstock Resources acquires Haynesville shale assets for $31M »

Comstock Resources, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

GRPN

Groupon

$4.76

0.04 (0.85%)

, IBM

IBM

$149.25

4.81 (3.33%)

19:16
07/19/18
07/19
19:16
07/19/18
19:16
Periodicals
Groupon lawyer says IBM shakes down other tech companies, Reuters says »

A lawyer for Groupon…

GRPN

Groupon

$4.76

0.04 (0.85%)

IBM

IBM

$149.25

4.81 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WDC

Western Digital

$77.45

-1.33 (-1.69%)

19:06
07/19/18
07/19
19:06
07/19/18
19:06
Hot Stocks
Western Digital begins sampling 1.33 terrabit 3D NAND »

Western Digital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CE

Celanese

$109.84

-1.17 (-1.05%)

, LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

CE

Celanese

$109.84

-1.17 (-1.05%)

LLNW

Limelight Networks

$4.69

-0.04 (-0.85%)

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

MSFT

Microsoft

$104.70

-0.38 (-0.36%)

SWKS

Skyworks

$102.46

0.41 (0.40%)

COF

Capital One

$95.32

-1.77 (-1.82%)

ETFC

E-Trade

$61.20

-1.94 (-3.07%)

PTCT

PTC Therapeutics

$36.61

1.59 (4.54%)

RWT

Redwood Trust

$16.64

0.135 (0.82%)

AEP

American Electric

$70.65

0.41 (0.58%)

WEC

WEC Energy

$65.23

0.51 (0.79%)

SKX

Skechers

$33.24

0.61 (1.87%)

FTD

FTD Companies

$4.52

0.06 (1.35%)

ZYNE

Zynerba

$10.40

0.24 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 27

    Aug

  • 04

    Sep

  • 20

    Jul

BG

Bunge

$67.99

-0.43 (-0.63%)

19:04
07/19/18
07/19
19:04
07/19/18
19:04
Periodicals
Bunge in talks to sell part of sugar trading unit to Wilmar, Bloomberg says »

Bunge is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

PEG

PSEG

$52.18

0.42 (0.81%)

18:42
07/19/18
07/19
18:42
07/19/18
18:42
Downgrade
PSEG rating change at Goldman Sachs »

PSEG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$65.23

0.51 (0.79%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
WEC Energy rating change at Goldman Sachs »

WEC Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$70.65

0.41 (0.58%)

18:41
07/19/18
07/19
18:41
07/19/18
18:41
Upgrade
American Electric rating change at Goldman Sachs »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ETR

Entergy

$80.97

0.465 (0.58%)

18:40
07/19/18
07/19
18:40
07/19/18
18:40
Upgrade
Entergy rating change at Goldman Sachs »

Entergy upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

, INCY

Incyte

$70.10

-0.3 (-0.43%)

18:33
07/19/18
07/19
18:33
07/19/18
18:33
Hot Stocks
Lancet study shows benefit of Baricitinib 4 mg for treatment of SLE »

Eli Lilly (LLY) and…

LLY

Eli Lilly

$89.45

-0.6 (-0.67%)

INCY

Incyte

$70.10

-0.3 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 31

    Jul

  • 10

    Sep

T

AT&T

$31.27

-0.46 (-1.45%)

18:20
07/19/18
07/19
18:20
07/19/18
18:20
Periodicals
U.S. court clears expedited appeal of AT&T-Time Warner deal, Reuters says »

A federal appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

VLKAY

Volkswagen

$0.00

(0.00%)

18:17
07/19/18
07/19
18:17
07/19/18
18:17
Periodicals
VW to furlough roughly 1,000 workers at biggest factory in Brazil, Reuters says »

Volkswagen intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

, GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

18:09
07/19/18
07/19
18:09
07/19/18
18:09
Periodicals
Google faces uphill but not insurmountable fight to appeal EU fine, WSJ says »

Google (GOOG) parent…

GOOG

Alphabet

$1,187.14

-8.67 (-0.73%)

GOOGL

Alphabet Class A

$1,199.26

-13.38 (-1.10%)

INTC

Intel

$52.01

0.3 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 18

    Sep

  • 28

    Oct

NWE

NorthWestern

$58.29

0.56 (0.97%)

18:03
07/19/18
07/19
18:03
07/19/18
18:03
Earnings
Breaking Earnings news story on NorthWestern »

NorthWestern reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.